Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 51Stomach Neoplasms 45Esophageal Neoplasms 42Colorectal Neoplasms 37Pancreatic Neoplasms 31Carcinoma, Hepatocellular 19Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 16Adenocarcinoma Of Esophagus 12Neoplasms 7Cholangiocarcinoma 6Peritoneal Neoplasms 4Neoplasm Metastasis 4Recurrence 3Liver Neoplasms 3Gastrointestinal Stromal Tumors 3Clinical Stage I Gastric Cancer AJCC v8 3Cirrhosis, Familial, with Pulmonary Hypertension 3Adenocarcinoma 3Pancreatic Intraductal Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Lymphatic Metastasis 2Biliary Tract Neoplasms 2Turcot syndrome 1Tissue Adhesions 1Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor 1Stomach Diseases 1Solid Pseudopapillary Neoplasm of the Pancreas 1Sleep Apnea Syndromes 1

Interventions

Gemcitabine 3Cisplatin 2durvalumab 1camrelizumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Simvastatin 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Biliary Tract Carcinoma × Surgical Procedures, Operative × Gastrointestinal × Clear all
NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

First Affiliated Hospital of Zhejiang University

Phase 2 Active not recruiting
30 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡